Stocks Hitting 52-Week Highs By: Benzinga via Benzinga October 06, 2014 at 10:15 AM EDT Durata Therapeutics (NASDAQ: DRTX) shares reached a new 52-week high of $23.66 after Actavis (NYSE: ACT) announced its plans to buy ... Read More >> Related Stocks: Actavis Plc Becton Dickinson Chimerix Inc